Results 91 to 100 of about 542,363 (307)

Assessment and Management of Cardiac Patients in a Dental Office: A Learning Module for Dental Students

open access: yes
Journal of Dental Education, EarlyView.
Thomas R. Stevenson   +3 more
wiley   +1 more source

Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Globally, cardiovascular diseases (CVDs) account for around one‐third of all deaths. Clinical trial evidence suggests that treatment of people with obesity or type 2 diabetes (T2D) and CVD with glucagon‐like peptide‐1 (GLP‐1) receptor agonists reduces the risk of major adverse cardiovascular events, heart failure outcomes and all‐cause ...
Naveed Sattar   +5 more
wiley   +1 more source

Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Cardiorenal effects of semaglutide in people with type 2 diabetes (T2D) at high cardiovascular (CV) risk were investigated. Materials and Methods Post hoc analyses of pooled SUSTAIN 6 (NCT01720446) and PIONEER 6 (NCT02692716) data assessed time to primary major adverse CV events (MACE; CV death, non‐fatal myocardial infarction, or non ...
Jingmin Zhou   +6 more
wiley   +1 more source

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase III clinical trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the efficacy and safety of adding lobeglitazone to a triple therapy regimen in Korean patients with type 2 diabetes whose blood glucose levels were inadequately controlled despite dual therapy with metformin and sitagliptin.
Eun‐Gyoung Hong   +18 more
wiley   +1 more source

Unstable Angina Pectoris

open access: yes, 1988
The introduction of intravenously administered nitrate formulations such as intravenous nitroglycerin and intravenous isosorbide dinitrate has markedly improved the conservative therapy of unstable angina. These formulations, originally used only in coronary care units, are now used in general medical wards and emergencies rooms, without hemodynamic ...
Marija Weiss, Adam Schneeweiss
openaire   +2 more sources

The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

open access: yesJournal of the American Medical Association (JAMA), 2000
E. Antman   +9 more
semanticscholar   +1 more source

A cost‐effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Effective weight management pharmacotherapies are a new alternative to bariatric surgery or health behaviour intervention (HBI) alone. Comparative cost‐effectiveness evaluations can guide decision‐making. We aimed to evaluate the cost‐effectiveness of sleeve gastrectomy (SG), Roux‐en‐Y gastric bypass (RYGB), semaglutide, tirzepatide, and ...
Nisha Gupta   +5 more
wiley   +1 more source

Vital systems, Grand body systems: Cardiovascular systems

open access: yesنشریه پرستاری ایران, 1995
Unstable angina has progressive process and even in rest time, it happens frequently. It is a serious situation and 15-20 percent of patients are dying in duration of one year. Treatment: patients often hospitalized because observation of their reactions
Farahaninia, M
doaj  

Home - About - Disclaimer - Privacy